Skip to main content

Mark Munger, PharmD, FCCP, FACC

Mark Munger, PharmD, FCCP, FACC, writes about medical matters of the heart and other internal organs.

Pharmacy Learning Network
Mark Munger, PharmD, discusses recent study findings, which show that ranolazine increases the adverse effect profile of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, raising concern for patient safety.
Pharmacy Learning Network
In the final part of this series, Mark Munger, PharmD, provides potential solutions and insights into the future of community pharmacy in this era of pharmacy benefit managers.
Pharmacy Learning Network
In part 2 of this series, Mark Munger, PharmD, explains why the consequences of PBM practices on community pharmacy have wide implications to society, the profession, and the US health care system overall.
Pharmacy Learning Network
In this 3-part series, Mark Munger, PharmD, highlights the impact pharmacy benefit managers have on community pharmacies. In part 1, Dr Munger provides details on why he believes PBMs are directly or indirectly contributing to the closure of community pharmacies.
Pharmacy Learning Network
Mark Munger, PharmD, discusses the importance of sleep and highlights why poor sleep quality increases the risk of high blood pressure, cardiovascular disease, diabetes, and more.
Pharmacy Learning Network
Mark Munger, PharmD, explains why the phenotypic presentation of heart failure must be studied and highlights why he believes new therapeutic targets are needed based on the changing heart failure phenotype.
Pharmacy Learning Network
Mark Munger, PharmD, discusses burnout among pharmacists, and explains why it is becoming more commonplace among this profession.
Pharmacy Learning Network
Mark Munger, PharmD, discusses potential harms related to the consumption of energy drinks and he explains why careful discussion in the profession is needed about the risk-benefit of these agents.
Pharmacy Learning Network
Mark Munger, PharmD, discusses the history and community pharmacy and explains changes happening in the field that may be putting the community pharmacy profession in jeopardy.
Pharmacy Learning Network
Mark Munger, PharmD, discusses a recent study that aimed to improve outcomes among patients with chronic heart failure with reduced ejection fractions using newer anti-coagulants.
Back to Top